In the field of cancer research, the KRAS gene has always occupied an important and unique position. For many years, due to its complex structure and functional characteristics, KRAS has been regarded as an "undruggable" target.
This reductive coupling process unfolds in two sequential stages. Initially, the coupling reaction is triggered by the transfer of a single electron from an alkali metal (potassium) to the carbonyl groups.
Polymethylhydrosiloxane (PMHS), a byproduct generated within the silicone manufacturing sector, serves as an economical, user-friendly, and eco-conscious reducing agent. Notably, PMHS exhibits superior stability in the presence of air and moisture compared to alternative silanes, enabling ...
In the rapidly evolving field of battery technology, combinations of chemical substances play a pivotal role, providing robust support for the exploration and development of new battery technologies. By optimizing various performance aspects of lithium-ion batteries, such as safety, energy ...
The primary distinction between Atomic Layer Deposition (ALD) and Chemical Vapor Deposition (CVD) is rooted in their deposition techniques, ability to regulate film characteristics, and appropriate applications. ALD is characterized by a step-by-step, self-terminating process that builds thin ...
Chemical vapor deposition (CVD) is a technique that employs gaseous or vaporized materials to react within the gas phase or at the gas-solid boundary, resulting in the formation of solid coatings. Atomic layer deposition (ALD), a specialized form of CVD, enables precise deposition at the atomic ...
High-purity monomers serve as essential raw materials in the manufacturing of ophthalmic products. Chemical impurities, or even fluctuations in the impurity profile, can adversely affect both the safety and comfort of contact lens wearers. Adding complexity to the supply chain, scaling up ...
KRAS (Kirsten Rat Sarcoma Viral Oncogene Homolog) is a key member of the RAS family. Mutations in KRAS are among the most common oncogenic drivers in several malignancies, including non-small cell lung cancer (NSCLC), pancreatic cancer, and colorectal cancer. It is estimated that KRAS mutations ...
Wir verwenden Cookies, um die ordnungsgemäße Funktion der Website sicherzustellen und, soweit zulässig, Ihr Nutzererlebnis zu verbessern. Sie können Ihre Einstellungen jederzeit unter „Einstellungen“ verwalten. Weitere Informationen finden Sie in unserer Cookie-Richtlinie.
Dürfen wir Sie über Rabattaktionen informieren?
Später erinnern
Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.